The latest price target for Assembly Biosciences (NASDAQ:ASMB) was reported by Guggenheim on March 25, 2025. The analyst firm set a price target for $31.00 expecting ASMB to rise to within 12 months ...
The average one-year price target for Assembly Biosciences (NASDAQ:ASMB) has been revised to 3.06 / share. This is an increase of 20.00% from the prior estimate of 2.55 dated August 1, 2023. The price ...
SAN FRANCISCO — Ambitious California climate change legislation cleared a significant hurdle in the state Assembly yesterday, but advocates warn more challenges lie ahead. SAN FRANCISCO — Ambitious ...
Guggenheim raised the firm’s price target on Assembly Biosciences (ASMB) to $39 from $31 and keeps a Buy rating on the shares. Following interim data from Assembly’s Phase 1b study released last month ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results